<p>獨立認可強調了 Cognizin® 在科學支持的認知表現領域的領導地位</p>
<p>, /PRNewswire/ -- Kyowa Hakko USA 今天宣佈，Cognizin®（胞苷酸），由 Kyowa Hakko Bio Co. 生產的胞苷酸品牌形式，已被全球市場情報公司 Mintel 和消費者分析領導者 Black Swan Data 認定為 “2026 年值得關注的功能性成分”。這一第三方驗證突顯了 Cognizin® 在快速增長的腦健康和心理表現市場中的核心地位。</p>
<p>繼續閲讀</p>
<p><img src="https://imageproxy.pbkrs.com/https://www.prnewswire.com/news-releases/null?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.prnewswire.com/news-releases/null"/></p>
<p>Cognizin 標誌</p>
<p>根據 Mintel/Black Swan 的分析，65% 的全球產品發佈包含 Cognizin®，並聲稱具有腦部或神經系統的益處，表明對基於證據的認知支持的強勁和加速需求。Cognizin® 現在以多種形式出現，從軟糖和棒棒糖到能量飲料和高級補充劑，使其成為當今功能性營養領域中最具多樣性和令人興奮的成分之一。</p>
<p>&#34;被評為 2026 年值得關注的成分不僅僅是一個美好的標題；它確認了配方師和消費者已經告訴我們的事實，&#34; Kyowa Hakko USA 科學事務高級經理 Katie Emerson, MS, RD 説。&#34;Cognizin® 不僅僅是貨架上擁擠的另一種智能藥物。它是一種經過臨牀研究、嚴格製造的成分，品牌圍繞其構建了整個產品故事。這一認可驗證了多年來對科學和質量的投資，並標誌着 Cognizin® 主流突破的開始。&#34;</p>
<p><strong>認可背後的數據</strong> Mintel/Black Swan 的研究突顯了塑造 Cognizin® 發展軌跡的幾個關鍵趨勢：</p>
<ul>
<li>強烈的腦健康關注：65% 的全球 Cognizin® 發佈聲稱具有腦部或神經系統的益處，使認知支持成為該成分的主導定位。</li>
<li>不斷增長的地理足跡：目前大多數發佈集中在北美（49%）和歐洲（34%），表明在其他地區有強勁的採用和巨大的增長機會。</li>
<li>多樣化的產品形式：Cognizin® 主要出現在營養飲料（36%）、能量飲料（32%）和補充劑（23%）中，以及功能性糖果和內在美容等新興形式。</li>
</ul>
<p>最近發佈的包含 Cognizin® 的產品包括科學支持的產品，如 Qunol、BUM Energy、MOSH 和 Magic Mind，展示了品牌如何利用 Cognizin® 在日常環境中提供益處。</p>
<p>&#34;看到 Cognizin® 在多種形式中出現強調了它的多樣性和影響力，&#34; Emerson 補充道。&#34;這告訴我們，認知支持不再是小眾，而是成為了基本期望。&#34;</p>
<p><strong>為什麼 Cognizin® 在擁擠的智能藥物市場中脱穎而出</strong> Cognizin® 是胞苷酸的品牌形式，一種支持磷脂酰膽鹼生產的營養素，磷脂酰膽鹼是腦細胞膜的關鍵成分，也是腦細胞能量的重要參與者。與許多普通的智能藥物不同，Cognizin® 擁有豐富的研究支持。</p>
<p><strong>關鍵差異化因素包括：</strong></p>
<ul>
<li>臨牀證據：研究表明，胞苷酸可以支持注意力、記憶和認知表現，包括基於 MRI 的研究顯示腦活動的變化。</li>
<li>腦能量支持研究表明，胞苷酸可以將腦 ATP（細胞能量）增加約 13%，直接支持心理能量和專注力。</li>
<li>非刺激性特徵：Cognizin® 提供認知益處，而不依賴於咖啡因或強刺激物，使其成為消費者的一個有吸引力的選擇。</li>
<li>質量和一致性：由 Kyowa Hakko 使用專有發酵技術和嚴格的質量控制生產，Cognizin® 為品牌和消費者提供一致的純度和可追溯性。</li>
</ul>
<p>&#34;在一個消費者越來越懷疑模糊的 ‘腦部提升’ 聲明的時代，Cognizin® 的科學優先故事顯得尤為重要，&#34; Emerson 説。&#34;品牌希望擁有能夠經得起高度知情的購物者評估的成分，而 Cognizin 正是如此。&#34;</p>
<p>這一認可也恰逢心理表現和倦怠成為頭條話題之際。最近的職場和健康研究表明，員工和消費者在專注、注意力和心理疲勞方面面臨挑戰。</p>
<p>&#34;2026 年將成為人們停止接受平庸過程和雜亂思維作為新常態的一年，&#34; Emerson 説。&#34;他們正在尋找能夠幫助他們在工作、健身房和家中保持敏鋭的實用工具。Cognizin® 為配方師提供了一種科學基礎的方法來構建這些解決方案。&#34;</p>
<p><strong>支持全球創新品牌</strong> “2026 年值得關注的功能性成分” 這一稱號已經激勵了飲料、補充劑和功能性食品領域的新合作和產品概念。Kyowa Hakko USA 正在通過以下方式擴大對合作夥伴的支持：</p>
<ul>
<li>針對飲料、粉末、軟糖和新型形式的配方指導</li>
<li>將複雜研究轉化為清晰消費者語言的基於科學的營銷資產</li>
<li>突出使用 Cognizin® 配方的品牌的聯合營銷機會</li>
<li>針對醫療專業人士、零售商和配方師的教育計劃</li>
</ul>
<p>&#34;我們現在看到的一些最令人興奮的創新來自於那些理解認知表現是新能量的品牌，&#34; Emerson 説。&#34;這些品牌選擇 Cognizin®，因為他們希望他們的產品能夠適應未來，並與市場的發展方向保持一致，而不是停留在過去。&#34;</p>
<p><strong>— Cognizin</strong> ® <strong>—</strong></p>
<p><strong>關於京和發酵美國</strong> 京和發酵美國是京和發酵生物有限公司的子公司，這是一家擁有超過 75 年發酵、純化和改性生物活性物質專業知識的全球生物技術公司。京和發酵生物致力於通過科學與自然創造創新解決方案，以改善全球人們的健康和福祉。憑藉尖端的研究能力，京和發酵生物致力於開發有科學證據支持的獨特成分。欲瞭解更多信息，請訪問 kyowa-usa.com。</p>
<p><strong>關於 Cognizin®</strong> Cognizin® 乙酰膽鹼是由京和發酵生物有限公司生產的一種經過臨牀研究的品牌形式的乙酰膽鹼，這是一種在體內天然合成的物質，對大腦健康尤為重要。乙酰膽鹼是一種強效的大腦健康營養素。Cognizin® 是一種專有形式的乙酰膽鹼，經過臨牀研究支持其對心理能量、專注力和注意力的支持。Cognizin® 通過發酵過程製造，確保高質量和高純度。Cognizin® 還具有高度穩定性，符合 GRAS 標準，超純且無過敏原。Cognizin® 可以作為膳食成分在美國銷售，用於補充劑、食品和飲料，並在歐盟被批准作為食品補充劑的新型食品成分。欲瞭解更多關於 Cognizin® 的信息，請訪問 Cognizin.com。</p>
<p>來源：京和發酵美國</p>
<p><img src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjYwMTIyJk5ld3NJdGVtSWQ9Tlk2ODI3NyZUcmFuc21pc3Npb25fSWQ9MjAyNjAxMjIwOTExUFJfTkVXU19VU1BSX19fX19OWTY4Mjc3?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjYwMTIyJk5ld3NJdGVtSWQ9Tlk2ODI3NyZUcmFuc21pc3Npb25fSWQ9MjAyNjAxMjIwOTExUFJfTkVXU19VU1BSX19fX19OWTY4Mjc3"/></p>

<p>Kyowa Hakko USA 宣佈，Cognizin®（胞苷酸）被 Mintel 和 Black Swan Data 評選為 “2026 年值得關注的功能性成分”。這一認可突顯了 Cognizin® 在日益增長的腦健康市場中的重要作用，全球 65% 的產品發佈都將其作為認知支持成分。該成分用途廣泛，出現在各種形式中，如軟糖和能量飲料，並且有臨牀研究支持其對注意力和記憶的益處。該稱號預計將激勵認知表現領域的新產品創新</p>

<p><em>Independent recognition underscores Cognizin®'s role as a</em> <em>science‑backed leader in cognitive performance</em></p>
<div class="lb-trans"><p>獨立認可強調了 Cognizin® 在科學支持的認知表現領域的領導地位</p>
</div><p>, /PRNewswire/ -- Kyowa Hakko USA today announced that Cognizin® (citicoline), the branded form of citicoline manufactured by Kyowa Hakko Bio Co., has been recognized as a leading &#34;Functional Ingredient to Watch in 2026&#34; by global market intelligence firm Mintel and consumer analytics leader Black Swan Data. This third‑party validation highlights Cognizin®'s position at the center of the rapidly growing brain health and mental performance market.</p>
<div class="lb-trans"><p>, /PRNewswire/ -- Kyowa Hakko USA 今天宣佈，Cognizin®（胞苷酸），由 Kyowa Hakko Bio Co. 生產的胞苷酸品牌形式，已被全球市場情報公司 Mintel 和消費者分析領導者 Black Swan Data 認定為 “2026 年值得關注的功能性成分”。這一第三方驗證突顯了 Cognizin® 在快速增長的腦健康和心理表現市場中的核心地位。</p>
</div><p>Continue Reading</p>
<div class="lb-trans"><p>繼續閲讀</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.prnewswire.com/news-releases/null" alt="" original-src="https://www.prnewswire.com/news-releases/null"/></p>
<p>Cognizin Logo</p>
<div class="lb-trans"><p>Cognizin 標誌</p>
</div><p>According to the Mintel/Black Swan analysis, 65% of global product launches featuring Cognizin® include a brain or nervous system benefit, signaling strong and accelerating demand for evidence‑based cognitive support. Cognizin® now appears across a wide range of formats, from gummies and lollipops to energy drinks and advanced supplements, making it one of the most versatile and exciting ingredients in the field of functional nutrition today.</p>
<div class="lb-trans"><p>根據 Mintel/Black Swan 的分析，65% 的全球產品發佈包含 Cognizin®，並聲稱具有腦部或神經系統的益處，表明對基於證據的認知支持的強勁和加速需求。Cognizin® 現在以多種形式出現，從軟糖和棒棒糖到能量飲料和高級補充劑，使其成為當今功能性營養領域中最具多樣性和令人興奮的成分之一。</p>
</div><p>&#34;Being named an ingredient to watch in 2026 is more than a nice headline; it confirms what formulators and consumers are already telling us,&#34; said Katie Emerson, MS, RD, Senior Manager, Scientific Affairs at Kyowa Hakko USA. &#34;Cognizin® isn't just another nootropic on a crowded shelf. It is a clinically researched, rigorously manufactured ingredient that brands are building entire product stories around. This recognition validates years of investment in science and quality and marks the beginning of Cognizin®'s mainstream breakout.&#34;</p>
<div class="lb-trans"><p>&#34;被評為 2026 年值得關注的成分不僅僅是一個美好的標題；它確認了配方師和消費者已經告訴我們的事實，&#34; Kyowa Hakko USA 科學事務高級經理 Katie Emerson, MS, RD 説。&#34;Cognizin® 不僅僅是貨架上擁擠的另一種智能藥物。它是一種經過臨牀研究、嚴格製造的成分，品牌圍繞其構建了整個產品故事。這一認可驗證了多年來對科學和質量的投資，並標誌着 Cognizin® 主流突破的開始。&#34;</p>
</div><p><strong>Data behind the recognition</strong> The Mintel/Black Swan work highlights several key trends shaping Cognizin®'s trajectory:</p>
<div class="lb-trans"><p><strong>認可背後的數據</strong> Mintel/Black Swan 的研究突顯了塑造 Cognizin® 發展軌跡的幾個關鍵趨勢：</p>
</div><ul>
<li>Strong brain‑health focus: 65% of global Cognizin® launches carry a brain or nervous system claim, making cognitive support the dominant positioning for the ingredient.</li>
<li>Growing geographic footprint: Most launches are currently concentrated in North America (49%) and Europe (34%), indicating both strong adoption and substantial opportunities for growth in other regions.</li>
<li>Diverse product formats: Cognizin® primarily appears in nutrition drinks (36%), energy drinks (32%), and supplements (23%), as well as emerging formats such as functional confections and beauty-from-within products.</li>
</ul>
<div class="lb-trans"><ul>
<li>強烈的腦健康關注：65% 的全球 Cognizin® 發佈聲稱具有腦部或神經系統的益處，使認知支持成為該成分的主導定位。</li>
<li>不斷增長的地理足跡：目前大多數發佈集中在北美（49%）和歐洲（34%），表明在其他地區有強勁的採用和巨大的增長機會。</li>
<li>多樣化的產品形式：Cognizin® 主要出現在營養飲料（36%）、能量飲料（32%）和補充劑（23%）中，以及功能性糖果和內在美容等新興形式。</li>
</ul>
</div><p>Recent launches featuring Cognizin® include science-backed products, such as Qunol, BUM Energy, MOSH, and Magic Mind, which showcase how brands use Cognizin® to deliver benefits in everyday settings.</p>
<div class="lb-trans"><p>最近發佈的包含 Cognizin® 的產品包括科學支持的產品，如 Qunol、BUM Energy、MOSH 和 Magic Mind，展示了品牌如何利用 Cognizin® 在日常環境中提供益處。</p>
</div><p>&#34;Seeing Cognizin® across a wide range of formats underscores its versatility and impact,&#34; Emerson added. &#34;It tells us cognitive support is no longer niche but has become a baseline expectation.&#34;</p>
<div class="lb-trans"><p>&#34;看到 Cognizin® 在多種形式中出現強調了它的多樣性和影響力，&#34; Emerson 補充道。&#34;這告訴我們，認知支持不再是小眾，而是成為了基本期望。&#34;</p>
</div><p><strong>Why Cognizin® stands out in a crowded nootropics landscape</strong> Cognizin® is a branded form of citicoline, a nutrient that supports the production of phosphatidylcholine, a key component of brain cell membranes and a critical player in brain cell energy. Unlike many generic nootropics, Cognizin® is backed by a substantial research portfolio.</p>
<div class="lb-trans"><p><strong>為什麼 Cognizin® 在擁擠的智能藥物市場中脱穎而出</strong> Cognizin® 是胞苷酸的品牌形式，一種支持磷脂酰膽鹼生產的營養素，磷脂酰膽鹼是腦細胞膜的關鍵成分，也是腦細胞能量的重要參與者。與許多普通的智能藥物不同，Cognizin® 擁有豐富的研究支持。</p>
</div><p><strong>Key differentiators include:</strong></p>
<div class="lb-trans"><p><strong>關鍵差異化因素包括：</strong></p>
</div><ul>
<li>Clinical evidence: Studies have demonstrated that citicoline can support attention, memory, and cognitive performance, including MRI-based research that shows changes in brain activity.</li>
<li>Brain energy support studies indicate citicoline can increase brain ATP (cellular energy) by approximately 13%, directly supporting mental energy and focus.</li>
<li>Non-stimulant profile: Cognizin® delivers cognitive benefits without relying on caffeine or harsh stimulants, making it an attractive option for consumers.</li>
<li>Quality and consistency: Produced by Kyowa Hakko using proprietary fermentation technology and strict quality controls, Cognizin® offers consistent purity and traceability for brands and consumers.</li>
</ul>
<div class="lb-trans"><ul>
<li>臨牀證據：研究表明，胞苷酸可以支持注意力、記憶和認知表現，包括基於 MRI 的研究顯示腦活動的變化。</li>
<li>腦能量支持研究表明，胞苷酸可以將腦 ATP（細胞能量）增加約 13%，直接支持心理能量和專注力。</li>
<li>非刺激性特徵：Cognizin® 提供認知益處，而不依賴於咖啡因或強刺激物，使其成為消費者的一個有吸引力的選擇。</li>
<li>質量和一致性：由 Kyowa Hakko 使用專有發酵技術和嚴格的質量控制生產，Cognizin® 為品牌和消費者提供一致的純度和可追溯性。</li>
</ul>
</div><p>&#34;In an era where consumers are increasingly skeptical of vague 'brain boosting' claims, Cognizin®'s science‑first story matters,&#34; Emerson said. &#34;Brands want ingredients that can stand up to evaluation from highly informed shoppers, and Cognizin does exactly that.&#34;</p>
<div class="lb-trans"><p>&#34;在一個消費者越來越懷疑模糊的 ‘腦部提升’ 聲明的時代，Cognizin® 的科學優先故事顯得尤為重要，&#34; Emerson 説。&#34;品牌希望擁有能夠經得起高度知情的購物者評估的成分，而 Cognizin 正是如此。&#34;</p>
</div><p>The recognition also comes at a moment when mental performance and burnout are front‑page topics. Recent workplace and health research shows that employees and consumers are struggling with focus, attention, and mental fatigue.</p>
<div class="lb-trans"><p>這一認可也恰逢心理表現和倦怠成為頭條話題之際。最近的職場和健康研究表明，員工和消費者在專注、注意力和心理疲勞方面面臨挑戰。</p>
</div><p>&#34;2026 is shaping up to be the year people stop accepting mediocre process and scattered thoughts as the new normal,&#34; Emerson said. &#34;They are looking for practical, daily tools that help them show up sharp—at work, in the gym, and at home. Cognizin® gives formulators a scientifically grounded way to build those solutions.&#34;</p>
<div class="lb-trans"><p>&#34;2026 年將成為人們停止接受平庸過程和雜亂思維作為新常態的一年，&#34; Emerson 説。&#34;他們正在尋找能夠幫助他們在工作、健身房和家中保持敏鋭的實用工具。Cognizin® 為配方師提供了一種科學基礎的方法來構建這些解決方案。&#34;</p>
</div><p><strong>Supporting innovator brands worldwide</strong> The &#34;Functional Ingredient to Watch in 2026&#34; designation is already inspiring new collaborations and product concepts across beverages, supplements, and functional foods. Kyowa Hakko USA is expanding its support for partners through:</p>
<div class="lb-trans"><p><strong>支持全球創新品牌</strong> “2026 年值得關注的功能性成分” 這一稱號已經激勵了飲料、補充劑和功能性食品領域的新合作和產品概念。Kyowa Hakko USA 正在通過以下方式擴大對合作夥伴的支持：</p>
</div><ul>
<li>Formulation guidance for beverages, powders, gummies, and novel formats</li>
<li>Science‑based marketing assets translating complex research into clear consumer language</li>
<li>Co‑marketing opportunities spotlighting brands that formulate with Cognizin®</li>
<li>Education initiatives for healthcare professionals, retailers, and formulators</li>
</ul>
<div class="lb-trans"><ul>
<li>針對飲料、粉末、軟糖和新型形式的配方指導</li>
<li>將複雜研究轉化為清晰消費者語言的基於科學的營銷資產</li>
<li>突出使用 Cognizin® 配方的品牌的聯合營銷機會</li>
<li>針對醫療專業人士、零售商和配方師的教育計劃</li>
</ul>
</div><p>&#34;Some of the most exciting innovations we're seeing right now are coming from brands that understand that cognitive performance is the new energy,&#34; Emerson said. &#34;Those brands are choosing Cognizin® because they want their products to be future‑proof and aligned with where the market is going, not where it's been.&#34;</p>
<div class="lb-trans"><p>&#34;我們現在看到的一些最令人興奮的創新來自於那些理解認知表現是新能量的品牌，&#34; Emerson 説。&#34;這些品牌選擇 Cognizin®，因為他們希望他們的產品能夠適應未來，並與市場的發展方向保持一致，而不是停留在過去。&#34;</p>
</div><p><strong>— Cognizin</strong> ® <strong>—</strong></p>
<div class="lb-trans"><p><strong>— Cognizin</strong> ® <strong>—</strong></p>
</div><p><strong>About Kyowa Hakko USA</strong> Kyowa Hakko USA is a subsidiary of Kyowa Hakko Bio Co., Ltd., a global biotechnology company with over 75 years of expertise in fermentation, purification, and modification of bioactive substances. Kyowa Hakko Bio is dedicated to improving the health and well-being of people worldwide by creating innovative solutions with science and nature. With cutting-edge research capabilities, Kyowa Hakko Bio is committed to developing unique ingredients supported by scientific evidence. For more information, visit kyowa-usa.com.</p>
<div class="lb-trans"><p><strong>關於京和發酵美國</strong> 京和發酵美國是京和發酵生物有限公司的子公司，這是一家擁有超過 75 年發酵、純化和改性生物活性物質專業知識的全球生物技術公司。京和發酵生物致力於通過科學與自然創造創新解決方案，以改善全球人們的健康和福祉。憑藉尖端的研究能力，京和發酵生物致力於開發有科學證據支持的獨特成分。欲瞭解更多信息，請訪問 kyowa-usa.com。</p>
</div><p><strong>About Cognizin®</strong> Cognizin® Citicoline, manufactured by Kyowa Hakko Bio Co., Ltd., is a clinically studied and branded form of citicoline, a natural substance made endogenously in the body and especially vital to brain health. Citicoline is a potent brain-health nutrient. A proprietary form of citicoline, Cognizin® has been clinically studied to support mental energy, focus, and attention. Cognizin® is manufactured through a fermentation process to yield high quality and high purity. Cognizin® is also highly stable, GRAS, ultra-pure, and allergen-free. Cognizin® can be sold as a dietary ingredient for supplements, foods, and beverages in the United States and is approved as a novel food ingredient in the EU for food supplements. For more information on Cognizin®, visit Cognizin.com.</p>
<div class="lb-trans"><p><strong>關於 Cognizin®</strong> Cognizin® 乙酰膽鹼是由京和發酵生物有限公司生產的一種經過臨牀研究的品牌形式的乙酰膽鹼，這是一種在體內天然合成的物質，對大腦健康尤為重要。乙酰膽鹼是一種強效的大腦健康營養素。Cognizin® 是一種專有形式的乙酰膽鹼，經過臨牀研究支持其對心理能量、專注力和注意力的支持。Cognizin® 通過發酵過程製造，確保高質量和高純度。Cognizin® 還具有高度穩定性，符合 GRAS 標準，超純且無過敏原。Cognizin® 可以作為膳食成分在美國銷售，用於補充劑、食品和飲料，並在歐盟被批准作為食品補充劑的新型食品成分。欲瞭解更多關於 Cognizin® 的信息，請訪問 Cognizin.com。</p>
</div><p>SOURCE Kyowa Hakko U.S.A</p>
<div class="lb-trans"><p>來源：京和發酵美國</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjYwMTIyJk5ld3NJdGVtSWQ9Tlk2ODI3NyZUcmFuc21pc3Npb25fSWQ9MjAyNjAxMjIwOTExUFJfTkVXU19VU1BSX19fX19OWTY4Mjc3" alt="" original-src="https://rt.prnewswire.com/rt.gif?NewsItemId=NY68277&amp;Transmission_Id=202601220911PR_NEWS_USPR_____NY68277&amp;DateId=20260122"/></p>

09:11 ET
			
			
				COGNIZIN® CITICOLINE NAMED "FUNCTIONAL INGREDIENT TO WATCH IN 2026" BY MINTEL & BLACK SWAN DATA, SHOWCASING ITS EXPLOSIVE GROWTH IN THE BRAIN HEALTH CATEGORY

COGNIZIN® CITICOLINE 被 Mintel 和 Black Swan Data 評選為 “2026 年值得關注的功能性成分”，展示了其在腦健康領域的迅猛增長